Use of theophylline in chronic obstructive pulmonary disease: examining the evidence
Author:
- 1 March 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 12 (2) , 132-139
Abstract
The role of theophylline in the management of chronic obstructive pulmonary disease remains controversial. This review was undertaken to determine the efficacy of theophylline in patients with stable disease. Twenty-two good quality randomized controlled trials were included in this systematic review. The review showed that theophylline significantly improved forced expiratory volume in 1 s and forced vital capacity (weighted mean difference 0.10 L; 95% confidence interval 0.04-0.16 and weighted mean difference 0.21 L; 95% confidence interval 0.10-0.31, respectively). V also improved with theophylline (weighted mean difference 195.27 mL/min; 95% confidence interval 112.71-277.83), as did Pa and Pa (weighted mean difference 1.45 mmHg; 95% confidence interval 0.26-2.65 and weighted mean difference -1.09 mmHg; 95% confidence interval -1.83 to -0.35, respectively). Patients preferred theophylline over placebo (relative risk 2.27; 95% confidence interval 1.26-4.11). Theophylline increased the risk of nausea, however, compared with placebo (relative risk 7.67; 95% confidence interval 1.47-39.94). This review has shown that oral theophylline plays an important role in the management of patients with stable chronic obstructive pulmonary disease by improving lung function, arterial blood gas tensions and ventilatory capacity. Patients also preferred treatment with theophylline when compared with placebo. The benefits of theophylline in stable chronic obstructive pulmonary disease, however, have to be weighed against the risk of adverse effects, particularly nausea.Keywords
This publication has 50 references indexed in Scilit:
- Effect of low‐dose theophylline on airway inflammation in COPDRespirology, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Exercise Limitations in Patients with Pulmonary DiseasesInternational Journal of Sports Medicine, 1994
- Lung function, hypoxic and hypercapnic ventilatory responses, and respiratory muscle strength in normal subjects taking oral theophylline.Thorax, 1990
- A Randomized, Controlled Trial of Theophylline in Patients with Severe Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1989
- Dose response relation to oral theophylline in severe chronic obstructive airways disease.BMJ, 1988
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Effects of Theophylline on Diaphragmatic Strength and Fatigue in Patients with Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1984
- THEOPHYLLINE PRESCRIBING, SERUM CONCENTRATIONS, AND TOXICITYThe Lancet, 1983
- Sustained-release theophylline in chronic bronchitisRespiratory Medicine, 1982